CYP2D6-inhibiting drugs and risk of fall injury after newly initiated therapy with beta-blockers—a register-based case-crossover study

Abstract We assessed whether concomitant use of CYP2D6-inhibiting drugs associates with increased risk of fall injuries after newly initiated therapy with beta-blockers. A case-crossover study design was applied which eliminates confounding from individual fixed characteristics by pairing cases with...

Full description

Bibliographic Details

Published in:	Scientific Reports
Main Authors:	Karin Leander, M.-L. Dahl, M. Vikström, J. Möller, K. Söderberg-Löfdal
Format:	Article
Language:	English
Published:	Nature Portfolio 2025-07-01
Subjects:	Accidental falls Beta-blocking agents Cytochrome P450 CYP2D6 inhibitors Drug interactions
Online Access:	https://doi.org/10.1038/s41598-025-09617-4